A SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations
J Clin Microbiol
.
2021 Jun 18;59(7):e0074121.
doi: 10.1128/JCM.00741-21.
Epub 2021 Jun 18.
Authors
Michelle Verghese
1
,
Becky Jiang
2
,
Naomi Iwai
2
,
Marilyn Mar
2
,
Malaya K Sahoo
1
,
Fumiko Yamamoto
1
,
Kenji O Mfuh
2
,
Jacob Miller
3
,
Hannah Wang
1
,
James Zehnder
1
,
Benjamin A Pinsky
1
2
4
Affiliations
1
Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
2
Clinical Virology Laboratory, Stanford Health Care, Stanford, California, USA.
3
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.
4
Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
PMID:
33952596
PMCID:
PMC8218743
DOI:
10.1128/JCM.00741-21
No abstract available
Keywords:
gene sequencing; genome analysis; molecular methods; virology.
Publication types
Letter
MeSH terms
COVID-19*
Humans
Mutation
Neutralization Tests
SARS-CoV-2*